Status:
UNKNOWN
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborating Sponsors:
Shanghai Municipal Hospital of Traditional Chinese Medicine
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Conditions:
Parkinson Disease
Dyskinesias
Eligibility:
All Genders
Brief Summary
Parkinson' patients who have not had dyskinesia would be observed for 2 years in a multicenter prospective study with the purposes to clarify the predicting factors of dyskinesia.
Detailed Description
Parkinson' patients with daily levodopa dosage above 200mg and no dyskinesia would be recruited into the study. They would be observed for two years for analyzed the predicting factors of dyskinesia. ...
Eligibility Criteria
Inclusion
- \- 1) Patients have been clinically diagnosed with Parkinson disease at the recruitment.
- 2\) Patients have received Levodopa treatment with the daily dosage above 200mg.
Exclusion
- 1\) be suspicious of atypical Parkinson or other Parkinson syndrome. 2) have experienced dyskinesia. 3) incorporation to the investigation
Key Trial Info
Start Date :
January 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04453995
Start Date
January 5 2019
End Date
June 1 2022
Last Update
July 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinhua hospital affiliated to Shanghai jiaotong university school of medicine
Shanghai, Shanghai Municipality, China, 200092